CZMGX
Price
$20.80
Change
-$0.18 (-0.86%)
Updated
Sep 25 closing price
Net Assets
102.95M
GFACX
Price
$74.20
Change
-$0.72 (-0.96%)
Updated
Sep 25 closing price
Net Assets
338.37B
Interact to see
Advertisement

CZMGX vs GFACX

Header iconCZMGX vs GFACX Comparison
Open Charts CZMGX vs GFACXBanner chart's image
Multi-Manager Growth Strategies Inst
Price$20.80
Change-$0.18 (-0.86%)
VolumeN/A
Net Assets102.95M
American Funds Growth Fund of Amer C
Price$74.20
Change-$0.72 (-0.96%)
VolumeN/A
Net Assets338.37B
CZMGX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CZMGX vs. GFACX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CZMGX is a Buy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. CZMGX (103M). CZMGX (0.00) and GFACX (0.00) have matching dividends . CZMGX was incepted earlier than GFACX: CZMGX (9 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than CZMGX (0.76). CZMGX is a more actively managed with annual turnover of: 52.00 vs. GFACX (25.00). CZMGX has a lower initial minimum investment than GFACX: CZMGX (100) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.71 vs. CZMGX (3.71). GFACX return over 5 years is better than : 37.51 vs. CZMGX (18.72).
CZMGXGFACXCZMGX / GFACX
Total Expense Ratio0.741.3654%
Annual Report Gross Expense Ratio0.761.3656%
Fund Existence9 years25 years-
Gain YTD2.04316.37412%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets103M338B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.7110.7135%
Returns for 3 years68.2465.29105%
Returns for 5 years18.7237.5150%
Returns for 10 yearsN/A93.03-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.840.43
+17.84%
CytomX Therapeutics
EPAC39.71-0.75
-1.85%
Enerpac Tool Group Corp
SOLV70.46-1.36
-1.89%
Solventum Corp
BAOS3.26-0.09
-2.69%
Baosheng Media Group Holdings Limited
YTRA1.42-0.08
-5.63%
Yatra Online